Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Auro Laboratories has informed BSE that its Board of Directors will meet on Thursday, February 5, 2026. The main agenda is to consider and approve the unaudited financial results for the quarter ended December 31, 2025, along with the Limited Review Report from auditors. The trading window for designated persons and their immediate relatives will remain closed until 48 hours after the board meeting concludes. This is a routine regulatory intimation under SEBI Listing Regulations, and no actual financial numbers have been disclosed yet.
Neutral in the short term — this is a procedural announcement ahead of the Q3 FY26 earnings release. Investors should watch for the actual results on or after February 5, 2026, which could move the stock depending on performance versus expectations.